The Effect of tDCS on Subcortical Brain Functioning
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain abilities related to cognition, emotion and/or physical functioning in individuals with subcortical brain damage.
| Condition | Intervention |
|---|---|
|
Brain Damage, Chronic |
Procedure: Transcranial Direct Current Stimulation (tDCS) |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | The Effect of Transcranial Direct Current Stimulation on Subcortical Brain Functioning |
| Estimated Enrollment: | 150 |
| Study Start Date: | February 2012 |
| Estimated Study Completion Date: | December 2015 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Individuals w/ subcortical brain damage
Individuals with subcortical brain damage resulting from Parkinson's disease, subcortical dementia (i.e., Huntington's disease, Parkinson's related dementia, Lewy Body dementia), stroke, anoxia, or other brain injury.
|
Procedure: Transcranial Direct Current Stimulation (tDCS)
Anodal, Cathodal or Sham tDCS
|
|
Control Group
Healthy controls with no known cognitive deficits
|
Procedure: Transcranial Direct Current Stimulation (tDCS)
Anodal, Cathodal or Sham tDCS
|
Detailed Description:
While cortical brain structures are thought to be responsible for higher level cognitive functioning (i.e., perception, thoughts, language, memory, attention, and processing), subcortical brain regions (i.e., amygdala, midbrain, hippocampus, and thalamus) are generally believed to be responsible for more fundamental bases of such functions. A significant fraction of the population suffer from disabling disorders and diseases (i.e., Parkinson's disease, subcortical dementia, hypoxic brain damage) that affect subcortical areas. Despite their prevalence, very little success has been achieved in treating such impairments effectively.
This study has two main goals. One is to examine the effect of stimulation on a variety of subcortical functions (i.e., level of alertness, mood, cognition, and motor responding). A second goal is to examine the effects of varying some of the stimulus parameters of tDCS, notably the placement of the electrodes and the duration and frequency of application of current.
Adult participants with a confirmed diagnosis of subcortical brain damage, as well as healthy adults will be randomly assigned to anodal and cathodal stimulation in a counterbalanced order, and both will engage in simple behavioral tasks and/or physiological monitoring. These tasks will be specific to the deficit of interest.
Eligibility| Ages Eligible for Study: | 18 Years to 79 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
You must also belong to one of two groups to join this study:
- Healthy adults with no known deficits in cognition
- Adults with dysfunction due to damage to subcortical brain structures (i.e., thalamus, basal ganglia, limbic system, etc.) which may be associated with diagnoses such as diagnoses of Parkinson's disease, Korsakoff's syndrome, bipolar disorder, schizophrenia, depression, subcortical dementia, thalamic hypoperfusion, etc.).
Inclusion Criteria:
- Fluent in the English language
- History of subcortical brain damage (patient group only)
- No known neurological or cognitive impairment (control group only)
Exclusion Criteria:
- Appreciable deficits in hearing
- Schizophrenia, bipolar disorder, or major depression (normal controls only)
- Any neurological disorder associated with cognitive impairment or neuroanatomic abnormality (normal controls only)
- Language-based learning disorder (normal controls only)
- Dementia or Mini-Mental State Exam <24 for normal control participants
- Any implanted metal device (precludes use of tDCS)
- Any implanted cardiac pacemaker
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Barry Gordon, M.D., Ph.D., Editor-in-Chief, Cognitive and Behavioral Neurology/Therapeutic Cognitive Neuroscience Professor/Professor of Neurology and Cognitive Science, Johns Hopkins University, Johns Hopkins University |
| ClinicalTrials.gov Identifier: | NCT01602276 History of Changes |
| Other Study ID Numbers: | 47863 |
| Study First Received: | May 14, 2012 |
| Last Updated: | October 31, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Johns Hopkins University:
|
Parkinson's disease Lewy body dementia Korsakoff's syndrome |
Additional relevant MeSH terms:
|
Brain Damage, Chronic Brain Injuries Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries |
ClinicalTrials.gov processed this record on May 23, 2013